Anticancer agent CHS 828 suppresses nuclear factor-kappa B activity in cancer cells through downregulation of IKK activity. [electronic resource]
Producer: 20040805Description: 198-205 p. digitalISSN:- 0020-7136
- Animals
- Apoptosis -- drug effects
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Small Cell -- pathology
- Cell Division
- Cyanides -- pharmacology
- Down-Regulation
- Female
- Guanidines -- pharmacology
- Humans
- I-kappa B Kinase
- Lung Neoplasms -- pathology
- Mice
- NF-kappa B -- metabolism
- Protein Serine-Threonine Kinases -- pharmacology
- Transplantation, Heterologous
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.